TS Financial Group (TSFG)’s Editas Medicine EDIT Stock Holding History

TS Financial Group (TSFG)’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-120	Closed	-$1K	–	803
2023 Q4	$1K	Hold	120	–	–	﹤0.01%	792
2023 Q3	$1K	Hold	120	–	–	﹤0.01%	928
2023 Q2	$1K	Hold	120	–	–	﹤0.01%	910
2023 Q1	$1K	Hold	120	–	–	﹤0.01%	883
2022 Q4	$1K	Hold	120	–	–	﹤0.01%	900
2022 Q3	$1K	Hold	120	–	–	﹤0.01%	873
2022 Q2	$1K	Hold	120	–	–	﹤0.01%	891
2022 Q1	$2K	Hold	120	–	–	﹤0.01%	780
2021 Q4	$3K	Hold	120	–	–	﹤0.01%	712
2021 Q3	$5K	Hold	120	–	–	﹤0.01%	646
2021 Q2	$7K	Hold	120	–	–	﹤0.01%	604
2021 Q1	$5K	Hold	120	–	–	﹤0.01%	582
2020 Q4	$8K	Hold	120	–	–	﹤0.01%	526
2020 Q3	$3K	Buy	+120	New	+$3.91K	﹤0.01%	597

Other funds holding EDIT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TS Financial Group (TSFG)'s EDIT Position: Q1 2024 in Review

TS Financial Group (TSFG) sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 120 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in EDIT in Q3 2020 and held it in 14 quarters. The position peaked at $8K in Q4 2020. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

TS Financial Group (TSFG) reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
TS Financial Group (TSFG) sold 120 Editas Medicine shares in Q1 2024, an estimated $1K.
TS Financial Group (TSFG) first reported a position in Editas Medicine in Q3 2020 and held it in 14 quarters.
TS Financial Group (TSFG)'s Editas Medicine position peaked at $8K in Q4 2020.
225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2024, filed 16 Apr 2024.